Letter to the editor: Subcutaneous sufentanil for palliative care patients in a hospital setting

Abstract

Get full access to this article

View all access options for this article.

References

Waara-Wolleat KL , Hildebrand KR , Stewart GR A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain . Pain Med 2006; 7(3): 251—9.

Vercauteren M. , Boeckx E. , Hanegreefs G. , Hoorduin H. , Vanden Bussche G. Intranasal sufentanil for pre-operative sedation . Anaesthesia 1988; 43: 270—3.

Helmers JH , Noorduin H. , Van Peer A. , Van Leeuwen L. , Zuurmond WWA Comparison of intravenous and intranasal sufentanil absorption and sedation . Can J Anaesth 1989; 36: 494—7.

Jackson K. , Ashby M. , Bush S. , Poon P. Pilot study: a phase I/II trial of intranasal sufentanil for breakthrough cancer associated pain . (abstract) 7th Australian Palliative Care Conference, Adelaide 2003.

Paix A. , Coleman A. , Lees J. et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management . Pain 1995; 63: 263—9.

Cheng CJ , Sia AT , Lim EH et al. Either sufentanil or fentanyl, in addition to intrathecal bupivacaine, provide satisfactory early labour analgesia . Can J Anaesth 2001; 48(6): 570—4.

Ahmedzai S. , Brooks D. Transdermal fentanyl versus sustained release oral morphine in cancer pain: preference, efficacy and quality of life. The TTS-fentanyl comparative trial group . J Pain Symptom Manage 1998; 16(3): 141—4.